Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06750094
Title A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy (OrigAMI-3)
Acronym OrigAMI-3
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Cancer and Blood Specialty Clinic RECRUITING Los Alamitos California 90720 United States Details
Providence Medical Foundation RECRUITING Santa Rosa California 95403 United States Details
MedStar Franklin Square Medical Center RECRUITING Baltimore Maryland 21237 United States Details
Concord Hospital RECRUITING Concord 2139 Australia Details
Warringal Private Hospital RECRUITING Heidelberg 3084 Australia Details
Queen Elizabeth Hospital RECRUITING South Woodville 5011 Australia Details
Western Health Sunshine Hospital RECRUITING St Albans 3021 Australia Details
University Malaya Medical Centre RECRUITING Kuala Lumpur 59100 Malaysia Details
Hospital Umum Sarawak RECRUITING Kuching 93586 Malaysia Details
Pan American Center for Oncology Trials LLC RECRUITING Barrio Monacillos 00935 Puerto Rico Details
Kaohsiung Medical University Chung Ho Memorial Hospital RECRUITING Kaohsiung 80756 Taiwan Details
National Taiwan University Hospital RECRUITING Taipei 10043 Taiwan Details
Taipei Veterans General Hospital RECRUITING Taipei 112 Taiwan Details
Linkou Chang Gung Memorial Hospital RECRUITING Taoyuan 333 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field